# Home Based Infusions for Ocrelizumab

> **NCT04650321** · PHASE4 · RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 110 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Ocrelizumab at home

## Key facts

- **NCT ID:** NCT04650321
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-01
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2021-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04650321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04650321, "Home Based Infusions for Ocrelizumab". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04650321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*